Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Lymphoma, Non-Hodgkin 3Lymphoma, T-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Hodgkin Disease 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasm Metastasis 1Medulloblastoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Histiocytosis, Langerhans-Cell 1Hepatoblastoma 1Glioma 1Ependymoma 1

Interventions

pembrolizumab 4Paclitaxel 2vocimagene amiretrorepvec 1stenoparib 1olaparib 1mirabegron 1epacadostat 1durvalumab 1ciforadenant 1cemiplimab 1atezolizumab 1advexin 1Temozolomide 1Rituximab 1Pharmacogenomic Variants 1Nivolumab 1LTX-315 1Ipilimumab 1IACS-010759 1HMPL-013 1Gemcitabine 1Fluorodeoxyglucose F18 1Flucytosine 1Carboplatin 1Capecitabine 1CPI-006 1Brentuximab Vedotin 1Bendamustine Hydrochloride 1Antibodies 1AZD5153 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Pharmacogenomic Variants × Lymphoid × Clear all
NCT03291938 2020-11-24

IACS-010759 in Advanced Cancers

M.D. Anderson Cancer Center

Phase 1 Completed
29 enrolled
BreastGastrointestinalLymphoid

Lymphoma, Neoplasm Metastasis, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡